Logo

    hma

    Explore " hma" with insightful episodes like "Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes", "Strategies for Secondary AML and Emerging Therapies for AML", "An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy", "Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications" and "Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications" from podcasts like ""CCO Oncology Podcast", "CCO Oncology Podcast", "CCO Oncology Podcast", "CCO Oncology Podcast" and "CCO Oncology Podcast"" and more!

    Episodes (6)

    Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

    Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

    In this podcast, Rami Komrokji, MD; María Díez Campelo, MD, PhD; and Amer Zeidan, MBBS, MHS answer questions from an audience of healthcare professionals on topics related to personalized management of myelodysplastic syndromes including:  

    • Practical use of the Molecular International Prognostic Scoring System  
    • Mutational targets and other treatments in ongoing clinical trials
    • Prophylaxis with venetoclax therapy
    • Best practices for bone marrow transplant, including induction and salvage regimens
    • Treatment options for hypoplastic myelodysplastic syndromes

    Presenters:
    Rami Komrokji, MD
    Professor
    Department of Oncologic Sciences
    University of South Florida  
    Vice Chair
    Malignant Hematology Department
    Moffitt Cancer Center
    Tampa, Florida

    María Díez Campelo, MD, PhD
    Associate Professor
    Department of Medicine
    School of Medicine
    University of Salamanca
    Hematologist
    Department of Hematology
    University Hospital of Salamanca
    Salamanca, Spain

    Amer Zeidan, MBBS, MHS
    Associate Professor, Internal Medicine
    Hematology
    Leader, Leukemia and Myeloid Disease Aligned Research Team (DART)
    Director, Hematology Early Therapeutics Research
    Yale Cancer Center and Smilow Cancer Hospital
    Yale University School of Medicine
    New Haven, Connecticut

    Link to full program, including downloadable slidesets, expert commentaries, and on-demand webcast:
    http://bit.ly/3YXgKK3

     

     

    Strategies for Secondary AML and Emerging Therapies for AML

    Strategies for Secondary AML and Emerging Therapies for AML

    In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:

    • Liposomal cytarabine plus daunorubicin for secondary AML
    • An overview of emerging immune-based strategies for AML
    • Evidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies

    Presenter:

    Sarah M. Tinsley, PhD, APRN, AOCN
    Nurse Practitioner
    Courtesy Assistant Professor
    Department of Malignant Hematology
    Moffitt Cancer Center
    University of South Florida
    Tampa, Florida

     

    An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

    An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

    In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses acute myeloid leukemia and management approaches for patients unfit for intensive chemotherapy, with a focus on the nursing perspective. Topics include:

    • An overview of AML
    • Identifying patients unfit for intensive therapy
    • Treatment options for unfit patients including venetoclax combinations
    • Adverse event profiles of treatment options
    • Nursing considerations for managing patients with AML unfit for intensive therapy

    Presenters:

    Ashley Leak Bryant, PhD, RN, OCN, FAAN
    Associate Professor
    School of Nursing
    UNC Lineberger Comprehensive Cancer Center  
    The University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina

     

    Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

    Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

    In this podcast episode,  Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses management strategies for lower-risk myelodysplastic syndrome (MDS) with a focus on the nursing perspective. Topics include

    • Risk scoring and treatment algorithms
    • Current and ongoing clinical trials in the lower-risk MDS setting
    • Adverse event profiles of current treatment options
    • Nursing considerations for managing a patient with lower-risk MDS

    Presenters:

    Ashley Leak Bryant, PhD, RN, OCN, FAAN
    Associate Professor
    School of Nursing
    UNC Lineberger Comprehensive Cancer Center  
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina

    Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

    Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

    In this podcast episode,Sarah Tinsley, PhD, APRN, AOCN, discusses management strategies for higher-risk and relapsed/refractory (R/R)  myelodysplastic syndromes (MDS) with a focus on the nursing perspective. Topics include:

    • Current and ongoing clinical trials in the higher-risk and R/R MDS setting
    • Therapies surrounding transplant
    • Nursing considerations for managing a patient with higher risk and/or R/R MDS

    Presenters:

    Sarah Tinsley, PhD, APRN, AOCN
    Nurse Practitioner
    Courtesy Assistant Professor
    Department of Malignant Hematology
    Moffitt Cancer Center
    University of South Florida
    Tampa, Florida

    Session 60 Junji Ito's Hanging Balloons, Fate Babylonia, MHA, JJK, Scary shit.

    Session 60 Junji Ito's Hanging Balloons, Fate Babylonia, MHA, JJK, Scary shit.

    WHAT THE FUCK IS UP SPOOKY KIDS. On this week's episode of the Monch Hours Podcast we start strong diving into Junji ito's Hanging Balloons. Followed by discussions of what we are watching such as, Fate Babylonia and Serial Experiments Lain. We finish out the episode going over this weeks Shonen Jump releases like My Hero Academia MHA and Jujutsu Kaisen JJK,

    Follow me on my socials for updates on when I go live.

    To talk all things anime, manga, and Otaku hit me up on Twitter https://twitter.com/HaunzzyVtuber

    IG is where I post my gaming and a variety of stuff https://instagram.com/haunzzy/

    Tik Tok is the same as IG for the most part https://tiktok.com/@haunzzyvtuber?lang=en

    SUPPORT https://streamlabs.com/haunzzy/tip​\